121 related articles for article (PubMed ID: 20020656)
1. [Kinetic features of ascites and solid Ehrlich tumors].
Moiseenko VM; Chudenko VA; Stukov AN; Anikin IV; Pozharisskiĭ KM; Maksimova NA
Vopr Onkol; 2009; 55(5):598-602. PubMed ID: 20020656
[TBL] [Abstract][Full Text] [Related]
2. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
3. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma.
Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Tomoyose T; Takano H; Funaki K; Fukuyama H; Takahashi T; Sakoda S
J Oral Pathol Med; 2005 Nov; 34(10):602-7. PubMed ID: 16202080
[TBL] [Abstract][Full Text] [Related]
4. [Electronic determination of the cell count and volume-distribution-curves during growth of Ehrlich ascites-tumor in mice].
Klugmann HJ; Hambsch K; Ludewig R
Arch Geschwulstforsch; 1969; 34(2):172-8. PubMed ID: 5397531
[No Abstract] [Full Text] [Related]
5. A comparison of cell proliferation parameters in solid and ascites Ehrlich tumors.
Tannock IF
Cancer Res; 1969 Aug; 29(8):1527-34. PubMed ID: 5807228
[No Abstract] [Full Text] [Related]
6. [Ki-67 and p53 expression as prognosticators of clinical course aggressiveness of squamous cell cancer of the larynx].
Gorban' NA; Ten VP; Pankratov VA
Vopr Onkol; 2007; 53(6):668-73. PubMed ID: 18416135
[TBL] [Abstract][Full Text] [Related]
7. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J
Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106
[TBL] [Abstract][Full Text] [Related]
8. Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma.
Raybaud H; Fortin A; Bairati I; Morency R; Monteil RA; Têtu B
Int J Oral Maxillofac Surg; 2000 Feb; 29(1):36-41. PubMed ID: 10691142
[TBL] [Abstract][Full Text] [Related]
9. Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanomas?
Kaleem Z; Lind AC; Humphrey PA; Sueper RH; Swanson PE; Ritter JH; Wick MR
Mod Pathol; 2000 Mar; 13(3):217-22. PubMed ID: 10757331
[TBL] [Abstract][Full Text] [Related]
10. Age-specific changes in the proliferation of Ehrlich ascites tumor cells grown as solid tumors.
Lala PK
Cancer Res; 1972 Mar; 32(3):628-36. PubMed ID: 5061312
[No Abstract] [Full Text] [Related]
11. Is conversion of solid into more anoxic ascites tumors associated with p53 inactivation?
Magnusson KP; Satalino R; Qian W; Klein G; Wiman KG
Oncogene; 1998 Nov; 17(18):2333-7. PubMed ID: 9811464
[TBL] [Abstract][Full Text] [Related]
12. Zinc deficiency and growth of Ehrlich ascites tumor.
Minkel DT; Dolhun PJ; Calhoun BL; Saryan LA; Petering DH
Cancer Res; 1979 Jul; 39(7 Pt 1):2451-6. PubMed ID: 445445
[TBL] [Abstract][Full Text] [Related]
13. Changes in cell population of Ehrlich ascites tumor by irradiation.
Tanaka N; Okumura Y; Murakami K
Strahlentherapie; 1978 Jul; 154(7):503-5. PubMed ID: 675734
[TBL] [Abstract][Full Text] [Related]
14. Inducible NO synthase inhibits the growth of free tumor cells, but enhances the growth of solid tumors.
Nishikawa M; Chang B; Inoue M
Carcinogenesis; 2004 Nov; 25(11):2101-5. PubMed ID: 15205363
[TBL] [Abstract][Full Text] [Related]
15. [Proliferation kinetics of Ehrlich ascites tumors during cisplatin administration].
Krug H; Taubert G; Lenschow S
Acta Histochem Suppl; 1990; 39():61-5. PubMed ID: 2080294
[TBL] [Abstract][Full Text] [Related]
16. P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy.
Lavertu P; Adelstein DJ; Myles J; Secic M
Laryngoscope; 2001 Nov; 111(11 Pt 1):1878-92. PubMed ID: 11801963
[TBL] [Abstract][Full Text] [Related]
17. p53 protein overexpression is associated with increased cell proliferation in patients with locally recurrent prostate carcinoma after radiation therapy.
Cheng L; Sebo TJ; Cheville JC; Pisansky TM; Slezak J; Bergstralh EJ; Pacelli A; Neumann RM; Zincke H; Bostwick DG
Cancer; 1999 Mar; 85(6):1293-9. PubMed ID: 10189134
[TBL] [Abstract][Full Text] [Related]
18. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.
Thapar K; Scheithauer BW; Kovacs K; Pernicone PJ; Laws ER
Neurosurgery; 1996 Apr; 38(4):765-70; discussion 770-1. PubMed ID: 8692397
[TBL] [Abstract][Full Text] [Related]
19. [Immunohistochemical study of p53 and Ki-67 in inverted papillomas and nasal polyps arising from nasal or paranasal regions].
Ikegawa K; Matsukuma S
Rinsho Byori; 2005 Jun; 53(6):499-503. PubMed ID: 16026075
[TBL] [Abstract][Full Text] [Related]
20. [Immunohistochemical study of p53 and Ki-67 antigen expression in bladder carcinoma].
Yuge F; Hirakata H; Igarashi H; Kodama M; Kawata N; Takimoto Y
Hinyokika Kiyo; 1999 Jul; 45(7):453-6. PubMed ID: 10466059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
